NYSE:STVN

Stevanato Group S.p.a Stock News

Healthcare > Medical - Instruments & Supplies

Buy STVN

*Your capital is at risk

$16.94

-0.600 (-3.42%)

At Close: Jun 22, 2026

Vaccine vial maker Stevanato raises $672 million in U.S. IPO

07:31pm, Thursday, 15'th Jul 2021

Stevanato Group S.p.A., an Italian maker of glass vials for COVID-19 vaccines and other healthcare products, raised $672 million in a downsized initial public offering on Thursday.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by